REBYOTA DIN 02555948
Health Canada record
| Active ingredient(s) | FECAL MICROBIOTA 50000000000 CFU |
|---|---|
| Dosage form | Suspension |
| Route | Rectal |
| Schedule | SCHEDULE D; PRESCRIPTION |
| Class | Human |
| ATC | A07FA ANTIDIARRHEAL MICROORGANISMS |
| Original market date | 10-Jun-2025 |
| Current status date | 10-Jun-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Ferring Inc. — licence 100274, currently licensed, last inspection rating C (2026-05-19).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 34958 | 2025-03-05 | New Drug Submission (NDS) |